期刊文献+

阿尔茨海默病患者视网膜结构及功能的改变 被引量:2

Changes in retinal structure and function of Alzheimer's patients
下载PDF
导出
摘要 阿尔茨海默病(Alzheimer's disease,AD)是一种神经退行性疾病,会出现记忆力下降、认知功能障碍、行为异常等表现。其特征性病理表现为Aβ蛋白沉积和神经纤维缠结,从而引起大脑的神经元细胞数量减少。视网膜作为中枢神经系统的外延,与中枢神经系统有着相似的组织解剖结构,Aβ斑在其中也有表达。并且,在对AD患者的眼科检查中发现,患者的视网膜出现神经节细胞数量减少、神经纤维层厚度变薄、黄斑容积变小及视网膜血管密度减少等异常变化,进而表现为视野缺损、对比敏感度下降等症状,出现了神经退行性改变。而且研究发现,视网膜的神经退行性病变早于大脑老年斑的形成。此外,研究发现,姜黄素是一种天然安全的荧光染料,可以标记视网膜Aβ斑。以上提示了视网膜有望成为AD的早期诊断窗口。 Alzheimer's disease(AD), a neurodegenerative disease, can result in memory loss,cognitive and behavioral deficits. The pathological hallmarkes are β amyloid plaques and neurofibrillary tangles which lead loss of neurons in brain. As the extension of the central nervous system, retina has a similar tissue anatomy with central nervous system. The β amyloid plaques have also been detected in retina of AD. Furthermore, according to eye examinations of AD patients, we have found the loss of retinal ganglion cells, the attenuation of retinal nerve fiber layer thickness, the smaller changes of macula lutea, the decline of vascular density and so on. And then, there occurs the visual field loss and the decline of contrast sensitivity and so on in AD patients. Thus, the retina has occurred nerve degenerative changes in AD. Meanwhile, there has been proved that the retina nerve degeneration is even earlier than senile plaques formation in brain. In addition,curcumin, a natural and safe fluorescent dye, can be used to label β amyloid plaques in retina. The above suggests that retina can be a window for the early diagnosis of AD.
作者 秦熙 卢艳
出处 《国际眼科杂志》 CAS 2017年第10期1867-1870,共4页 International Eye Science
基金 北京市科委首都特色(No.Z141107002514116)~~
关键词 阿尔茨海默病 视网膜病变 姜黄素 Β-淀粉样蛋白 综述 Alzheimer's disease retinopathy curcumin β amyloid review
  • 相关文献

参考文献9

二级参考文献142

  • 1田金洲,时晶,张学凯,倪敬年,张伯礼,王永炎.2011年美国阿尔茨海默病最新诊断标准解读[J].中国医学前沿杂志(电子版),2011,3(4):91-100. 被引量:62
  • 2彭丹涛,许贤豪,刘江红,矫玉娟,张华,殷剑,孟晓梅,谢琰臣,冯凯.简易智能精神状态检查量表检测老年期痴呆患者的应用探讨[J].中国神经免疫学和神经病学杂志,2005,12(4):187-190. 被引量:151
  • 3方芳,晏勇,冯占辉,刘祥琴,文明,黄华.多因素损伤的老年性痴呆动物模型的实验研究[J].重庆医学,2007,36(2):146-148. 被引量:8
  • 4肖淑杰.老年痴呆的临床及康复现状[J].中国康复研究中心学刊,1992,1(3):27-27.
  • 5Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol,2003,60 ( 8 ) : 1119-1122.
  • 6Blanks JC, Schmidt SY, Torigoe Y, et al. Retinal pathology in Alzheimer's disease. Ⅱ. Regional neuron loss and glial changes in GCL. Neurobiol Aging, 1996,17 ( 3 ) : 385-395.
  • 7Blanks JC, Torigoe Y, Hinton DR, et al. Retinal pathology in Alzhei- mer's disease. Ⅰ. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging, 1996,17 ( 3 ) :377-384.
  • 8Hinton DR, Sadun AA, Blanks JC, et al. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med, 1986,315 ( 8 ) :485-487.
  • 9Goldman JS, Hou CE. Early-onset Alzheimer disease : when is genet- ic testing appropriate? Alzheimer Dis Assoc Disord,2004,18 (2) : 65-67.
  • 10Samura E, Shoji M, Kawarabayashi T, et al. Enhanced accumulation of tau in doubly transgenie mice expressing mutant betaAPP and pr- esenilin-1. Brain Res ,2006,1094 ( 1 ) : 192-199.

共引文献20

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部